Literature DB >> 26707316

Liver Transplantation in Patients With Niemann-Pick Disease--Single-Center Experience.

G R Coelho1, A M Praciano2, J P C Rodrigues2, C F G Viana3, K P Brandão3, J T Valenca4, J H P Garcia5.   

Abstract

Niemann-Pick disease (NPD) is a rare syndrome caused by abnormal intracellular sphingomyelin lipid storage in cells known as "Pick cells." NPD can start in childhood or develop insidiously, with a predilection for reticuloendothelial cells and the nervous system. NPD is a heterogeneous clinical, and biomolecular disorder which has 6 variants. There is no curable treatment for NPD. Generally, the treatment for all types of Niemann-Pick disease is to support. Type B NPD (NPD-B) is mostly characterized by hepatosplenomegaly, which can evolve to hepatic cirrhosis. In patients who progress to liver failure, liver transplantation may be improve liver function. The Transplant Service of Hospital Universitário Walter Cantídio performed its first liver transplants in patients with NPD-B with good results, demonstrating the efficacy of this procedure in selected cases.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26707316     DOI: 10.1016/j.transproceed.2015.10.051

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

Review 1.  Types A and B Niemann-Pick disease.

Authors:  Edward H Schuchman; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2016-12-16       Impact factor: 4.797

2.  Case Report of Gastrointestinal Bleeding in an Adult with Chronic Visceral Acid Sphingomyelinase Deficiency.

Authors:  David Cassiman; Louis Libbrecht; Wouter Meersseman; Alexander Wilmer
Journal:  Case Rep Gastrointest Med       Date:  2019-04-04

3.  Impact of Intravenous Trehalose Administration in Patients with Niemann-Pick Disease Types A and B.

Authors:  Moein Mobini; Shabnam Radbakhsh; Francyne Kubaski; Peyman Eshraghi; Saba Vakili; Rahim Vakili; Manijeh Khalili; Majid Varesvazirian; Tannaz Jamialahmadi; Seyed Ali Alamdaran; Seyed Javad Sayedi; Omid Rajabi; Seyed Ahmad Emami; Željko Reiner; Amirhossein Sebkar
Journal:  J Clin Med       Date:  2022-01-04       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.